Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 7/9/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Stephen Tingley?

Stephen K. Tingley

Vice President Sales and Marketing Bioprocessing

Repligen Corporation

HQ Phone:  (781) 250-0111

Direct Phone: (781) ***-****direct phone

Email: s***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Repligen Corporation

41 Seyon Street Building #1, Suite 100

Waltham, Massachusetts,02453

United States

Company Description

Repligen Corporation (NASDAQ:RGEN) is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences a...more

Background Information

Employment History

Director, Business Development

Isogen LLC


Vice President Sales and Marketing Bioprocessing

Novasep Inc


Vice President of Corporate Development

BioProcessors Corporation


Director of Marketing

Millipore Corporation


Affiliations

IBC USA Conferences Inc

Scientific Advisor


Education

University of Leeds , England


Web References(33 Total References)


Leadership | Repligen

www.repligen.com [cached]

Stephen Tingley, Vice President, Sales
A graduate from the University of Leeds, England, Stephen Tingley has been recognized contributor to the bioprocessing industry for over 25 years. Having worked initially for GSK, Mr. Tingley then joined Millipore creating and sharing expertise in sterile and downstream processing. At Millipore, Mr. Tingley became a recognized early champion of the development and adoption of single use technologies. He has had experience commercializing several leading technologies, including massively parallel microbioreactors system for upstream process development, multi-column chromatography and, most recently, leading the disposable chromatography team at Repligen that developed the OPUS® pre-packed column line.


www.repligen.com

Stephen Tingley, Vice President, Sales and Marketing
A graduate from the University of Leeds, England, Stephen Tingley has been a recognized contributor to the bioprocessing industry for over 25 years. Having worked initially for GSK, Mr. Tingley then joined Millipore creating and sharing expertise in sterile and downstream processing. At Millipore, Mr. Tingley became a recognized early champion of the development and adoption of single use technologies. He has had experience commercializing several leading technologies, including massively parallel microbioreactors system for upstream process development, multi-column chromatography and, most recently, leading the disposable chromatography team at Repligen that developed the OPUS® pre-packed column product line.


www.processdevelopmentforum.com

Resistance to adoption of continuous manufacturing upstream has "historically been based on the unreliability and complexity of equipment such as cell retention devices, bioreactors, and associated control equipment," say Steve Tingley, vice-president, BioProcess Sales and Marketing, Repligen, and John Bonham-Carter, director, ATF Systems, but they add that many of these concerns are no longer relevant because of the invention of more reliable bioreactor controllers and devices.
"Adoption of continuous downstream is limited by technological immaturity," say Tingley and Bonham-Carter. "Currently, only a minority of bioreactors are specified with perfusion capability; however, there is a clear awareness that new facilities must be flexible and adaptable to perfusion technology," assert Tingley and Bonham-Carter. Full process implementation of continuous processing is still in its early days, say Tingley and Bonham-Carter. Companies that are incorporating end-to-end processing in their R&D operations have the opportunity to be "champions in advancing the best continuous processing technologies to clinical and commercial production over the next decade," according to Tingley and Bonham-Carter.


www.snl.com

Stephen Tingley
Vice President, Bioprocessing Sales and Marketing


www.secreflo.com

Stephen Tingley
Vice President, Bioprocessing Business Development


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory